Acute respiratory failure — structured approach
Type I vs II · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Type I (hypoxaemic): PaO₂ <8 kPa with normal/low CO₂ — V/Q mismatch, shunt or diffusion failure (pneumonia, oedema, ARDS, PE). Type II (hypercapnic): PaCO₂ >6 kPa with acidosis — pump failure (drive, muscle, chest wall) or airways obstruction. The gas plus the A–a gradient localises the lesion.
Red flags
- Normal or rising CO₂ in a tiring asthmatic = pre-arrest
- Falling respiratory rate in exhaustion is decompensation, not improvement
Assessment
Investigations
- ABG with FiO₂ recorded; A–a gradient (normal gradient + hypercapnia = pure hypoventilation, e.g. opioids)
- CXR ± ultrasound; ECG; targeted bloods
- In neuromuscular disease: serial vital capacity — the gas fails LAST
Management
- Correct life-threatening hypoxaemia first: titrated high-flow O₂
- Type I: treat the cause; CPAP/HFNO for recruitable disease (oedema, pneumonia); lung-protective invasive ventilation for ARDS
- Type II with acidosis: NIV early (COPD pH 7.25–7.35); reverse drive suppressants (naloxone), clear obstruction, support the fatiguing pump
- Re-gas after every intervention — the pH trend decides escalation
- Intubate for: refractory hypoxaemia, worsening acidosis/CO₂ despite NIV, exhaustion, airway or conscious-level failure
Classify the failure (oxygenation vs ventilation), then choose the tool: O₂, CPAP, NIV or the tube.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.